Related Experiment Video
Updated: Jan 15, 2026
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
A novel murine model for sporadic, malignant peripheral nerve sheath tumors, driven by BrafV600E and Pten loss
Julien Debbache1, Myriam Gwerder1, Elisabeth Rushing2
1University of Zurich, Institute of Anatomy, Winterthurerstrasse 190, 8057 Zürich, Switzerland.
Abstract:
Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas with limited therapeutic options. Here, we present a novel sporadic murine model of Nf1 wild-type MPNST, driven by conditional expression of oncogenic BrafV600E and loss of Pten in the glial lineage using the Plp1::CreERT2 driver. This model allows for highly penetrant and rapid tumor induction through spontaneous formation, localized initiation, or cell transplantation. Comparative analysis with Tyr::CreERT2-driven melanoma revealed striking phenotypic divergence despite shared genetic alterations, underscoring the importance of the cell of origin in shaping tumor identity. In this system, MPNST cells show refractory capacities to induce melanocytic trans-differentiation upon melanoma-promoting signaling cues, such as canonical Wnt signaling gain of function or increased of levels of the epigenetic mark H3K27Me3 upon Ezh2 gain of function. Our findings emphasize the significance of lineage context in tumor initiation and provide a foundation for future mechanistic and therapeutic studies.
Insights
We developed a new mouse model for malignant peripheral nerve sheath tumors (MPNSTs) by altering specific genes in glial cells. This model helps study MPNST development and potential treatments, highlighting the importance of cell origin in cancer.
Area of Science:
- Oncology
- Cancer Biology
- Genetics
Background:
- Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive cancers with few treatment options.
- Understanding MPNST development requires effective experimental models.
Purpose of the Study:
- To create a novel, sporadic mouse model for wild-type neurofibromatosis type 1 (Nf1) MPNST.
- To investigate the role of cell of origin in MPNST development and characteristics.
Main Methods:
- Conditional expression of oncogenic BrafV600E and Pten loss in glial cells using the Plp1::CreERT2 driver.
- Tumor induction via spontaneous formation, localized initiation, or cell transplantation.
- Comparative analysis with melanoma models (Tyr::CreERT2-driven).
Main Results:
- A highly penetrant and rapid MPNST model was established.
- Phenotypic divergence observed between MPNST and melanoma despite shared genetic alterations.
- MPNST cells demonstrated resistance to melanocytic trans-differentiation induced by Wnt signaling or H3K27Me3/Ezh2 alterations.
Conclusions:
- The cell of origin significantly influences tumor identity and characteristics.
- This model provides a platform for studying MPNST mechanisms and therapeutic strategies.
- Lineage context is crucial for tumor initiation and progression.
More Related Videos
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
